Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China flag China · Delayed Price · Currency is CNY
13.52
+0.02 (0.15%)
Feb 3, 2026, 3:04 PM CST

SHE:002675 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
2,7262,8463,2673,5653,8973,402
Other Revenue
23.3523.358.2418.3415.0216.85
2,7502,8693,2763,5833,9123,419
Revenue Growth (YoY)
-3.62%-12.42%-8.58%-8.41%14.42%14.24%
Cost of Revenue
1,3601,5211,9222,0512,3241,756
Gross Profit
1,3901,3481,3541,5321,5881,663
Selling, General & Admin
765.05724.93754.41785.29802.41889.04
Research & Development
300.36291.91197.22163.52137.56109.39
Other Operating Expenses
35.5331.7633.8729.1933.3430.95
Operating Expenses
1,1131,065980.31980.56974.771,038
Operating Income
276.73282.61373.77551.72612.99625.11
Interest Expense
-122.43-96.51-56.76-58.64-56.45-47.8
Interest & Investment Income
5.795.5612.7813.25.1212.25
Currency Exchange Gain (Loss)
15.4415.4415.2542.65-4.08-3.67
Other Non Operating Income (Expenses)
0.97-2.79-1.17-5.94-2.58-3.69
EBT Excluding Unusual Items
176.51204.31343.86542.97555582.2
Impairment of Goodwill
-52.6-52.6--80.1-211.26-
Gain (Loss) on Sale of Investments
-15.81-12.92-28.13-39.21-12.151.05
Gain (Loss) on Sale of Assets
0.330.21-0.23-0.38-0.15-1.29
Asset Writedown
-35.38-33.21---0.16-0.32
Other Unusual Items
113.31113.3121.7722.324.8229.74
Pretax Income
186.35219.1337.28445.58356.1611.37
Income Tax Expense
72.0277.6883.0792.7595.2593.9
Earnings From Continuing Operations
114.32141.43254.22352.83260.85517.47
Minority Interest in Earnings
51.7542.4-44.48-45.54-109.29-99.71
Net Income
166.07183.83209.74307.29151.56417.77
Net Income to Common
166.07183.83209.74307.29151.56417.77
Net Income Growth
82.92%-12.35%-31.75%102.75%-63.72%170.02%
Shares Outstanding (Basic)
825825825808802802
Shares Outstanding (Diluted)
825825825808802802
Shares Change (YoY)
0.04%-0.01%2.10%0.68%0.01%0.02%
EPS (Basic)
0.200.220.250.380.190.52
EPS (Diluted)
0.200.220.250.380.190.52
EPS Growth
82.85%-12.35%-33.15%101.38%-63.73%169.97%
Free Cash Flow
158.02-168.94-235606.93413.42310.39
Free Cash Flow Per Share
0.19-0.20-0.280.750.520.39
Dividend Per Share
0.0300.0800.1250.1500.1500.250
Dividend Growth
-82.86%-36.00%-16.67%--40.00%-
Gross Margin
50.54%46.97%41.34%42.77%40.59%48.65%
Operating Margin
10.06%9.85%11.41%15.40%15.67%18.28%
Profit Margin
6.04%6.41%6.40%8.58%3.87%12.22%
Free Cash Flow Margin
5.75%-5.89%-7.17%16.94%10.57%9.08%
EBITDA
435.93432.69511.69672.09727.92727.85
EBITDA Margin
15.85%15.08%15.62%18.76%18.61%21.29%
D&A For EBITDA
159.2150.08137.92120.37114.93102.74
EBIT
276.73282.61373.77551.72612.99625.11
EBIT Margin
10.06%9.85%11.41%15.40%15.67%18.28%
Effective Tax Rate
38.65%35.45%24.63%20.82%26.75%15.36%
Revenue as Reported
2,7502,8693,2763,5833,9123,419
Advertising Expenses
-0.51.060.830.290.15
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.